The IPO of Sudeep Pharma, sized at ₹895 crore, saw overwhelming demand and will have its share allotment finalised today.
The IPO of Sudeep Pharma, sized at ₹895 crore, saw overwhelming demand and will have its share allotment finalised today.
Sun Pharma has broken a long-standing downward trendline on its weekly chart, triggering signals that the stock may push higher over the coming months.
In the 1990s, Royal Enfield — then a faded British marque — underwent a quiet revival under Eicher Motors.
For nearly six years, Indiabulls Housing Finance (IHFL) and its former promoter Sameer Gehlaut have faced a stream of accusations including loan evergreening, share-price manipulation, kickbacks, and circular fund movements.
For years, most big Indian IT firms shied away from launching corporate venture-capital (CVC) arms — a tool that global tech giants use to spot disruption early and invest in emerging technologies.
Jefferies on LG Electronics – TP Rs. 1980 – Buy
Strong play on India discretionary; premium brand recall and strong distribution moats.
STUDDS Accessories Q2 Results
Net Profit Rs. 20.62 cr. up 18% YoY and 2% QoQ.
Revenue Rs. 154 cr. up 6% YoY and 3% QoQ.
EBITDA Rs. 29.84 cr. up 12% YoY but down 1% QoQ.
EBITDA margin at 19.32%, higher YoY but lower QoQ.
As discussed yesterday, market behaviour remained on expected lines. Nifty opened near our support of 25837 (opened at 25842.95), defended the level successfully, and then rallied sharply up to 26215.15.
1. FIIs net long position at 17.18%
2. PCR at 1.55
3. VIX at 11.96 (-2.29%)
4. FIIs bought 4778 cr in cash, 790.40 cr in index futures & 1778.70 cr in stock futures.
DIIs bought 6247.90 cr in cash.
Pro Fin Capitalto review 25% stake buy at Rs.22 per share and 1:1 bonus issue at its 26 November board meeting.
For those of you who are serious about having more, doing more, giving more and being more, success is achievable with some understanding of what to do.
